Literature DB >> 17948921

A mechanistic latent variable model for estimating drug concentrations in the male genital tract: a case study in drug kinetics.

Leena Choi1, Brian Caffo, Charles Rohde, Themba T Ndovi, Craig W Hendrix.   

Abstract

The purpose of this study is to develop statistical methodology to facilitate indirect estimation of the concentration of antiretroviral drugs and viral loads in the prostate gland and the seminal vesicle. The differences in antiretroviral drug concentrations in these organs may lead to suboptimal concentrations in one gland. Suboptimal levels of the antiretroviral drugs may not be able to fully suppress the virus in that gland, leading to a source of sexually transmissible virus and increasing the chance of selecting for a drug-resistant virus. This information may be useful for selecting an antiretroviral drug regimen that will achieve optimal concentrations in the genital tract glands. Using fractionally collected semen ejaculates, Lundquist (Acta Physiol. Scand. 1949; 19:1-95) measured levels of surrogate markers in each fraction that are uniquely produced by specific male accessory glands. To determine the original glandular concentrations of the surrogate markers, Lundquist solved a simultaneous series of linear equations. This method has several limitations. In particular, it does not yield a unique solution, it does not address measurement error, and it does not provide population-averaged estimates after taking into account inter-subject variability in the parameters. To cope with these limitations, we developed a mechanistic latent variable model based on the physiology of the male genital tract and surrogate markers. We employ a Bayesian approach and perform a sensitivity analysis on the distributional assumptions on the random effects and priors. The model and Bayesian approach are validated on experimental data where the concentration of a drug should be (biologically) differentially distributed between the two glands. In this example, the Bayesian model-based conclusions are found to be robust to model specification and this hierarchical approach leads to more scientifically valid conclusions than the original methodology. In particular, unlike existing methods, the proposed model-based approach was not affected by a common form of outliers.

Mesh:

Substances:

Year:  2008        PMID: 17948921      PMCID: PMC2763330          DOI: 10.1002/sim.3097

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  11 in total

1.  Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.

Authors:  Leena Choi; Francesca Dominici; Scott L Zeger; Peter Ouyang
Journal:  Stat Med       Date:  2005-09-30       Impact factor: 2.373

2.  Studies on the biochemistry of human semen; the viscosimetric determination of hyaluronidase.

Authors:  F LUNDQUIST
Journal:  Acta Physiol Scand       Date:  1949-01-31

3.  Drug concentration heterogeneity facilitates the evolution of drug resistance.

Authors:  T B Kepler; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-29       Impact factor: 11.205

4.  Quantitative assessment of seminal vesicle and prostate drug concentrations by use of a noninvasive method.

Authors:  Themba T Ndovi; Leena Choi; Brian Caffo; Teresa Parsons; Sharon Baker; Ming Zhao; Charles Rohde; Craig W Hendrix
Journal:  Clin Pharmacol Ther       Date:  2006-08       Impact factor: 6.875

5.  Pharmacokinetic profiles of nevirapine and indinavir in various fractions of seminal plasma.

Authors:  R M van Praag; S Repping; J W de Vries; J M Lange; R M Hoetelmans; J M Prins
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

6.  Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir.

Authors:  S Taylor; D J Back; S M Drake; J Workman; H Reynolds; S E Gibbons; D J White; D Pillay
Journal:  J Antimicrob Chemother       Date:  2001-09       Impact factor: 5.790

7.  A new method to estimate quantitatively seminal vesicle and prostate gland contributions to ejaculate.

Authors:  Themba T Ndovi; Teresa Parsons; Leena Choi; Brian Caffo; Charles Rohde; Craig W Hendrix
Journal:  Br J Clin Pharmacol       Date:  2006-10-31       Impact factor: 4.335

8.  Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men.

Authors:  Jade Ghosn; Marie-Laure Chaix; Gilles Peytavin; Elisabeth Rey; Jean-Louis Bresson; Cécile Goujard; Christine Katlama; Jean-Paul Viard; Jean-Marc Tréluyer; Christine Rouzioux
Journal:  AIDS       Date:  2004-09-24       Impact factor: 4.177

9.  Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients.

Authors:  Caroline Solas; Alain Lafeuillade; Philippe Halfon; Stéphane Chadapaud; Gilles Hittinger; Bruno Lacarelle
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

10.  Penetration of didanosine in semen of HIV-1-infected men.

Authors:  M Cruciani; G Liuzzi; A Chirianni; S Audagnotto; S Bonora; A Di Biagio; A Sinicco; M Bassetti; G Gatti
Journal:  J Antimicrob Chemother       Date:  2006-03-23       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.